Fineline Cube

Follow:
14422 Articles
Achilles Therapeutics and AstraZeneca Seal $12 Billion Deal for TRACERx NSCLC Study Data
CompanyDeals

Achilles Therapeutics and AstraZeneca Seal $12 Billion Deal for TRACERx NSCLC Study Data

Nuvation Bio's Taletrectinib NDA for ROS1+ NSCLC Receives FDA Priority Review
CompanyDrug

Nuvation Bio’s Taletrectinib NDA for ROS1+ NSCLC Receives FDA Priority Review

Shanghai Henlius Biotech Initiates Patient Dosing in Global Phase III ELAINE-3 Study for Lasofoxifene
CompanyDrug

Shanghai Henlius Biotech Initiates Patient Dosing in Global Phase III ELAINE-3 Study for Lasofoxifene

RaysightMed's AngioQFA 100 Receives NMPA Approval for Coronary Artery Function Measurement
CompanyMedical Device

RaysightMed’s AngioQFA 100 Receives NMPA Approval for Coronary Artery Function Measurement

uBriGene Secures RMB 200 Million in Pre-Series D Financing to Expand ATMPs CDMO Services
CompanyDeals

uBriGene Secures RMB 200 Million in Pre-Series D Financing to Expand ATMPs CDMO Services

WuXi AppTec to Divest WuXi Advanced Therapies and Oxford Genetics to Altaris LLC
CompanyDeals

WuXi AppTec to Divest WuXi Advanced Therapies and Oxford Genetics to Altaris LLC

Basecare Medical and SolarCare Form Alliance to Advance AI in IVF Services
CompanyDeals

Basecare Medical and SolarCare Form Alliance to Advance AI in IVF Services

Alphamab Oncology's JSKN033 Gets Green Light for Phase I/II Study from China's CDE
CompanyDrug

Alphamab Oncology’s JSKN033 Gets Green Light for Phase I/II Study from China’s CDE

CSPC Pharmaceutical's SYH2062 Receives NMPA Clearance for Hypertension Treatment
CompanyDrug

CSPC Pharmaceutical’s SYH2062 Receives NMPA Clearance for Hypertension Treatment

Keymed Biosciences' Kangyueda Approved for CRSwNP Treatment in China
CompanyDrug

Keymed Biosciences’ Kangyueda Approved for CRSwNP Treatment in China

Sichuan Biokin's GNC-038 Tetra-Specific Antibody Clears for Clinical Trials in Autoimmune Diseases
CompanyDrug

Sichuan Biokin’s GNC-038 Tetra-Specific Antibody Clears for Clinical Trials in Autoimmune Diseases

Changchun High & New Technology Industries Receives FDA Approval for Menopausal VMS Drug Trial
CompanyDrug

Changchun High & New Technology Industries Receives FDA Approval for Menopausal VMS Drug Trial